Updated on 12 September 2012
What it offers instead is rich intellectual capital in a well-connected environment, embodied in the world-renowned Biopolis campus and the growing academic medical centers.
No clear winners yet
The clinical trial market and its nimble players are clearly moving fast and converging in Asia.
While Asia offers golden opportunities, its diversity in culture, economic progress, regulations and political systems imply that each country has its fair share of both strengths and weaknesses.
The interplay between various stakeholders and factors will be dynamic and it will be interesting to see which country emerges at the forefront of clinical trials.